Any Role of PIK3CA and PTEN Biomarkers in the Prognosis in Oral Squamous Cell Carcinoma?
- PMID: 33287350
- PMCID: PMC7761816
- DOI: 10.3390/life10120325
Any Role of PIK3CA and PTEN Biomarkers in the Prognosis in Oral Squamous Cell Carcinoma?
Abstract
Oral squamous cell carcinoma (OSCC) accounts for 95% of the lesions in the oral cavity. Despite development in OSCC management, the outcome is still unsatisfactory. Identification of new therapies in OSCC is urgently needed. One objective of such treatment may be a signaling pathway of phosphatidylinositol 3-kinase. The study group included 92 patients treated for OSCC at the University Clinical Centre in Gdańsk, Poland. Study was performed on formalin-fixed paraffin-embedded samples from primary OSCC. Phosphatidylinositol-4,5-bisphosphate 3-kinase (PIK3CA) and phosphatase and tensin homolog encoded on chromosome 10 (PTEN) protein expression was assessed by immunohistochemistry (IHC). PIK3CA gene copy number was analyzed using chromogenic and silver in situ hybridization where molecular probes are marked by chromogens and silver ions. PIK3CA IHC H-score ≥ 70 was found in 51.65% patients, and loss of PTEN protein was noticed in 31.46% cases. PIK3CA amplification was detected in 5 tumors. In the case of PTEN protein expression, there was an inverse correlation with the T stage of the primary tumor (r = -0.243) and positive correlation with a 5-year survival (r = 0.235). The number of copies of the PIK3CA gene was associated with the tumor grading (r = 0.208). The present study shows that loss of PTEN protein and the grading (p = 0.040), distant metastases (p = 0.033), smoking (p = 0.016), and alcohol abuse (p = 0.042) were prognostic factors for the survival of patients with OSCC. In contrast, the presence of amplification and OSCC on the floor of the mouth resulted in a nearly six-fold increase in the risk of shortening survival (p = 0.037). Our finding suggests a potential prognostic significance of PTEN loss and PIK3CA amplification in OSCC. Future studies are needed to confirm our results.
Keywords: PIK3CA amplification; PTEN loss; oral squamous cell carcinoma; phosphatidylinositol 3-kinase pathway.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Prognostic value of the PIK3CA, AKT, and PTEN mutations in oral squamous cell carcinoma: literature review.Arch Med Sci. 2020 Nov 13;17(1):207-217. doi: 10.5114/aoms.2020.100780. eCollection 2021. Arch Med Sci. 2020. PMID: 33488873 Free PMC article.
-
Mutational analysis of PTEN/PIK3CA/AKT pathway in oral squamous cell carcinoma.Oral Oncol. 2011 Oct;47(10):946-50. doi: 10.1016/j.oraloncology.2011.07.013. Epub 2011 Aug 6. Oral Oncol. 2011. PMID: 21824802
-
Genetic alterations and expression of PTEN and its relationship with cancer stem cell markers to investigate pathogenesis and to evaluate prognosis in hepatocellular carcinoma.J Clin Pathol. 2019 Sep;72(9):588-596. doi: 10.1136/jclinpath-2019-205769. Epub 2019 May 24. J Clin Pathol. 2019. PMID: 31126975
-
PTEN allelic loss is an important mechanism in the late stage of development of oral leucoplakia into oral squamous cell carcinoma.Histopathology. 2018 Jan;72(2):330-338. doi: 10.1111/his.13381. Epub 2017 Nov 3. Histopathology. 2018. PMID: 28858374
-
Characterization of DJ-1, PTEN, and p-Akt as Prognostic Biomarkers in the Progression of Oral Squamous Cell Carcinoma.Cureus. 2023 Jan 31;15(1):e34436. doi: 10.7759/cureus.34436. eCollection 2023 Jan. Cureus. 2023. PMID: 36874678 Free PMC article.
Cited by
-
Review of Disease-Specific microRNAs by Strategically Bridging Genetics and Epigenetics in Oral Squamous Cell Carcinoma.Genes (Basel). 2023 Aug 2;14(8):1578. doi: 10.3390/genes14081578. Genes (Basel). 2023. PMID: 37628629 Free PMC article. Review.
-
Combined PIK3CA and SOX2 Gene Amplification Predicts Laryngeal Cancer Risk beyond Histopathological Grading.Int J Mol Sci. 2024 Feb 26;25(5):2695. doi: 10.3390/ijms25052695. Int J Mol Sci. 2024. PMID: 38473941 Free PMC article.
-
Epigenetic Regulation in Oral Squamous Cell Carcinoma Microenvironment: A Comprehensive Review.Cancers (Basel). 2023 Nov 27;15(23):5600. doi: 10.3390/cancers15235600. Cancers (Basel). 2023. PMID: 38067304 Free PMC article. Review.
-
A micro-peptide encoded by HOXB-AS3 promotes the proliferation and viability of oral squamous cell carcinoma cell lines by directly binding with IGF2BP2 to stabilize c-Myc.Oncol Lett. 2021 Oct;22(4):697. doi: 10.3892/ol.2021.12958. Epub 2021 Aug 2. Oncol Lett. 2021. PMID: 34457052 Free PMC article.
-
NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma.Cancer Gene Ther. 2023 May;30(5):752-765. doi: 10.1038/s41417-022-00578-8. Epub 2023 Jan 12. Cancer Gene Ther. 2023. PMID: 36635327 Free PMC article.
References
-
- Ferlay J., Ervik M., Lam F., Colombet M., Mery L., Piñeros M., Znaor A., Soerjomataram I., Bray F. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. [(accessed on 7 January 2019)];2018 Available online: https://gco.iarc.fr/today.
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous